KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Depreciation & Amortization (IS)EBIATLeasesMachine, Furnitures, Fixtures & OtherNon-Current ReceivablesOther Gross PP&E AdjustmentsReceivables - Other
Ratios

TherapeuticsMD (TXMD) Depreciation Expense (2018 - 2023)

TherapeuticsMD's Depreciation Expense history spans 7 years, with the latest figure at $100000.0 for Q4 2023.

  • For Q4 2023, Depreciation Expense fell 50.0% year-over-year to $100000.0; the TTM value through Dec 2023 reached $228000.0, down 77.25%, while the annual FY2023 figure was $100000.0, 83.33% down from the prior year.
  • Depreciation Expense reached $100000.0 in Q4 2023 per TXMD's latest filing, down from $128000.0 in the prior quarter.
  • In the past five years, Depreciation Expense ranged from a high of $329000.0 in Q1 2022 to a low of $66556.0 in Q2 2019.
  • Average Depreciation Expense over 3 years is $185222.3, with a median of $200000.0 recorded in 2022.
  • Peak YoY movement for Depreciation Expense: soared 63.22% in 2019, then tumbled 50.0% in 2023.
  • A 3-year view of Depreciation Expense shows it stood at $66556.0 in 2019, then surged by 200.5% to $200000.0 in 2022, then crashed by 50.0% to $100000.0 in 2023.
  • Per Business Quant, the three most recent readings for TXMD's Depreciation Expense are $100000.0 (Q4 2023), $128000.0 (Q2 2023), and $200000.0 (Q4 2022).